Sam Rothstein

Sam Rothstein is the lead inventor of Qrono’s Eloquent™ cancer therapy platform and a company co-founder. He brings more than 12 years of experience in the design of complex drug products and has led $4 million of Small Business Innovation Research projects on their development. At Qrono, Dr. Rothstein works closely with Dr. Little and Dr. Ferris to identify clinical needs and create matching cancer therapies. Prior to becoming Qrono’s CEO in 2017, he served as the company’s CSO. In this role, he worked with FDA scientists to develop bio-equivalence guidance for long acting injections. Dr. Rothstein holds chemical engineering degrees from Bucknell University and the University of Pittsburgh.